An Epidemiological Study Aimed to Record Standard Daily Practice in Managing Patients With Hypercholesterolemia

AstraZeneca

Status: Completed

Conditions: Hypercholesterolemia

Study type: Observational

Funder types: Industry

Identifiers

NCT01206231

NIS-CRS-DUM-2010/1

Details and patient eligibility

About

This study is aimed to collect the following Serbia-specific epidemiology data on hypercholesterolemia: patents characteristics, patients' management/treatment and physicians' standard practice. In addition, the aim is to determine the proportion of patients on lipid-lowering pharmacological treatment who have reached the LDL-C and HDL-C treatment goals.

Enrollment: 330 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with hypercholesterolemia currently receiving a lipid lowering agent

Exclusion criteria

• Pregnancy and lactation.

Trial design

330 participants in 1 patient group

1

Description:

Patients with hypercholesterolemia